Report Detail

Request for Sample of this report

Pharma & Healthcare Global Human Recombinant SCF Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4648926
    • |
  • 18 November, 2025
    • |
  • Global
    • |
  • 107 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Human Recombinant SCF market size was valued at US$ 60.7 million in 2024 and is forecast to a readjusted size of USD 109 million by 2031 with a CAGR of 8.4% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Human recombinant stem cell factor (SCF) is a glycoprotein that is produced through recombinant DNA technology. It is designed to mimic the natural stem cell factor, which plays a crucial role in the body. Natural SCF is a cytokine that binds to its receptor, c-Kit, present on the surface of various cell types, including hematopoietic stem cells, mast cells, and melanocytes. Human recombinant SCF is manufactured by inserting the gene encoding SCF into host cells, such as bacteria or mammalian cells, which then produce the protein. This recombinant form has similar biological functions to the native SCF. It promotes cell survival, proliferation, and differentiation of stem cells and other cell populations. In the context of medical research and applications, human recombinant SCF can be used in areas such as hematopoietic stem cell transplantation, where it helps in mobilizing and expanding hematopoietic stem cells. It also has potential in treating certain blood disorders and in tissue engineering, as it can stimulate the growth and development of relevant cell types, and contribute to the regeneration and repair of tissues. Overall, human recombinant SCF provides a consistent and controllable source of the cytokine for both research and therapeutic purposes, enabling scientists and medical professionals to study and manipulate cell behavior more effectively.
This report is a detailed and comprehensive analysis for global Human Recombinant SCF market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Human Recombinant SCF market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031
Global Human Recombinant SCF market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031
Global Human Recombinant SCF market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031
Global Human Recombinant SCF market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/g), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Recombinant SCF
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Recombinant SCF market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include STEMCELL Technologies, Sino Biological, R&D Systems, SigmaAldrich, AJINOMOTO, Proteintech Group, Inc, Thermo Fisher Scientific Inc., Qkine, Cell Signaling Technology, FUJIFILM Irvine Scientific, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Human Recombinant SCF market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Native-like Human Recombinant SCF
Modified Human Recombinant SCF
Market segment by Application
Medical
Biological Research
Major players covered
STEMCELL Technologies
Sino Biological
R&D Systems
SigmaAldrich
AJINOMOTO
Proteintech Group, Inc
Thermo Fisher Scientific Inc.
Qkine
Cell Signaling Technology
FUJIFILM Irvine Scientific
Kingfisher Biotech, Inc.
Prospec
Miltenyi Biotec
Applied Biological Materials (abm) Inc
Abcam
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Recombinant SCF product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Recombinant SCF, with price, sales quantity, revenue, and global market share of Human Recombinant SCF from 2020 to 2025.
Chapter 3, the Human Recombinant SCF competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Recombinant SCF breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Human Recombinant SCF market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Recombinant SCF.
Chapter 14 and 15, to describe Human Recombinant SCF sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Human Recombinant SCF Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Native-like Human Recombinant SCF
    • 1.3.3 Modified Human Recombinant SCF
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Human Recombinant SCF Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Medical
    • 1.4.3 Biological Research
  • 1.5 Global Human Recombinant SCF Market Size & Forecast
    • 1.5.1 Global Human Recombinant SCF Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Human Recombinant SCF Sales Quantity (2020-2031)
    • 1.5.3 Global Human Recombinant SCF Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 STEMCELL Technologies
    • 2.1.1 STEMCELL Technologies Details
    • 2.1.2 STEMCELL Technologies Major Business
    • 2.1.3 STEMCELL Technologies Human Recombinant SCF Product and Services
    • 2.1.4 STEMCELL Technologies Human Recombinant SCF Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 STEMCELL Technologies Recent Developments/Updates
  • 2.2 Sino Biological
    • 2.2.1 Sino Biological Details
    • 2.2.2 Sino Biological Major Business
    • 2.2.3 Sino Biological Human Recombinant SCF Product and Services
    • 2.2.4 Sino Biological Human Recombinant SCF Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Sino Biological Recent Developments/Updates
  • 2.3 R&D Systems
    • 2.3.1 R&D Systems Details
    • 2.3.2 R&D Systems Major Business
    • 2.3.3 R&D Systems Human Recombinant SCF Product and Services
    • 2.3.4 R&D Systems Human Recombinant SCF Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 R&D Systems Recent Developments/Updates
  • 2.4 SigmaAldrich
    • 2.4.1 SigmaAldrich Details
    • 2.4.2 SigmaAldrich Major Business
    • 2.4.3 SigmaAldrich Human Recombinant SCF Product and Services
    • 2.4.4 SigmaAldrich Human Recombinant SCF Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 SigmaAldrich Recent Developments/Updates
  • 2.5 AJINOMOTO
    • 2.5.1 AJINOMOTO Details
    • 2.5.2 AJINOMOTO Major Business
    • 2.5.3 AJINOMOTO Human Recombinant SCF Product and Services
    • 2.5.4 AJINOMOTO Human Recombinant SCF Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 AJINOMOTO Recent Developments/Updates
  • 2.6 Proteintech Group, Inc
    • 2.6.1 Proteintech Group, Inc Details
    • 2.6.2 Proteintech Group, Inc Major Business
    • 2.6.3 Proteintech Group, Inc Human Recombinant SCF Product and Services
    • 2.6.4 Proteintech Group, Inc Human Recombinant SCF Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Proteintech Group, Inc Recent Developments/Updates
  • 2.7 Thermo Fisher Scientific Inc.
    • 2.7.1 Thermo Fisher Scientific Inc. Details
    • 2.7.2 Thermo Fisher Scientific Inc. Major Business
    • 2.7.3 Thermo Fisher Scientific Inc. Human Recombinant SCF Product and Services
    • 2.7.4 Thermo Fisher Scientific Inc. Human Recombinant SCF Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
  • 2.8 Qkine
    • 2.8.1 Qkine Details
    • 2.8.2 Qkine Major Business
    • 2.8.3 Qkine Human Recombinant SCF Product and Services
    • 2.8.4 Qkine Human Recombinant SCF Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Qkine Recent Developments/Updates
  • 2.9 Cell Signaling Technology
    • 2.9.1 Cell Signaling Technology Details
    • 2.9.2 Cell Signaling Technology Major Business
    • 2.9.3 Cell Signaling Technology Human Recombinant SCF Product and Services
    • 2.9.4 Cell Signaling Technology Human Recombinant SCF Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Cell Signaling Technology Recent Developments/Updates
  • 2.10 FUJIFILM Irvine Scientific
    • 2.10.1 FUJIFILM Irvine Scientific Details
    • 2.10.2 FUJIFILM Irvine Scientific Major Business
    • 2.10.3 FUJIFILM Irvine Scientific Human Recombinant SCF Product and Services
    • 2.10.4 FUJIFILM Irvine Scientific Human Recombinant SCF Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 FUJIFILM Irvine Scientific Recent Developments/Updates
  • 2.11 Kingfisher Biotech, Inc.
    • 2.11.1 Kingfisher Biotech, Inc. Details
    • 2.11.2 Kingfisher Biotech, Inc. Major Business
    • 2.11.3 Kingfisher Biotech, Inc. Human Recombinant SCF Product and Services
    • 2.11.4 Kingfisher Biotech, Inc. Human Recombinant SCF Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Kingfisher Biotech, Inc. Recent Developments/Updates
  • 2.12 Prospec
    • 2.12.1 Prospec Details
    • 2.12.2 Prospec Major Business
    • 2.12.3 Prospec Human Recombinant SCF Product and Services
    • 2.12.4 Prospec Human Recombinant SCF Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Prospec Recent Developments/Updates
  • 2.13 Miltenyi Biotec
    • 2.13.1 Miltenyi Biotec Details
    • 2.13.2 Miltenyi Biotec Major Business
    • 2.13.3 Miltenyi Biotec Human Recombinant SCF Product and Services
    • 2.13.4 Miltenyi Biotec Human Recombinant SCF Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Miltenyi Biotec Recent Developments/Updates
  • 2.14 Applied Biological Materials (abm) Inc
    • 2.14.1 Applied Biological Materials (abm) Inc Details
    • 2.14.2 Applied Biological Materials (abm) Inc Major Business
    • 2.14.3 Applied Biological Materials (abm) Inc Human Recombinant SCF Product and Services
    • 2.14.4 Applied Biological Materials (abm) Inc Human Recombinant SCF Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Applied Biological Materials (abm) Inc Recent Developments/Updates
  • 2.15 Abcam
    • 2.15.1 Abcam Details
    • 2.15.2 Abcam Major Business
    • 2.15.3 Abcam Human Recombinant SCF Product and Services
    • 2.15.4 Abcam Human Recombinant SCF Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Abcam Recent Developments/Updates

3 Competitive Environment: Human Recombinant SCF by Manufacturer

  • 3.1 Global Human Recombinant SCF Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Human Recombinant SCF Revenue by Manufacturer (2020-2025)
  • 3.3 Global Human Recombinant SCF Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Human Recombinant SCF by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Human Recombinant SCF Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Human Recombinant SCF Manufacturer Market Share in 2024
  • 3.5 Human Recombinant SCF Market: Overall Company Footprint Analysis
    • 3.5.1 Human Recombinant SCF Market: Region Footprint
    • 3.5.2 Human Recombinant SCF Market: Company Product Type Footprint
    • 3.5.3 Human Recombinant SCF Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Human Recombinant SCF Market Size by Region
    • 4.1.1 Global Human Recombinant SCF Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Human Recombinant SCF Consumption Value by Region (2020-2031)
    • 4.1.3 Global Human Recombinant SCF Average Price by Region (2020-2031)
  • 4.2 North America Human Recombinant SCF Consumption Value (2020-2031)
  • 4.3 Europe Human Recombinant SCF Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Human Recombinant SCF Consumption Value (2020-2031)
  • 4.5 South America Human Recombinant SCF Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Human Recombinant SCF Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Human Recombinant SCF Sales Quantity by Type (2020-2031)
  • 5.2 Global Human Recombinant SCF Consumption Value by Type (2020-2031)
  • 5.3 Global Human Recombinant SCF Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Human Recombinant SCF Sales Quantity by Application (2020-2031)
  • 6.2 Global Human Recombinant SCF Consumption Value by Application (2020-2031)
  • 6.3 Global Human Recombinant SCF Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Human Recombinant SCF Sales Quantity by Type (2020-2031)
  • 7.2 North America Human Recombinant SCF Sales Quantity by Application (2020-2031)
  • 7.3 North America Human Recombinant SCF Market Size by Country
    • 7.3.1 North America Human Recombinant SCF Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Human Recombinant SCF Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Human Recombinant SCF Sales Quantity by Type (2020-2031)
  • 8.2 Europe Human Recombinant SCF Sales Quantity by Application (2020-2031)
  • 8.3 Europe Human Recombinant SCF Market Size by Country
    • 8.3.1 Europe Human Recombinant SCF Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Human Recombinant SCF Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Human Recombinant SCF Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Human Recombinant SCF Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Human Recombinant SCF Market Size by Region
    • 9.3.1 Asia-Pacific Human Recombinant SCF Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Human Recombinant SCF Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Human Recombinant SCF Sales Quantity by Type (2020-2031)
  • 10.2 South America Human Recombinant SCF Sales Quantity by Application (2020-2031)
  • 10.3 South America Human Recombinant SCF Market Size by Country
    • 10.3.1 South America Human Recombinant SCF Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Human Recombinant SCF Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Human Recombinant SCF Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Human Recombinant SCF Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Human Recombinant SCF Market Size by Country
    • 11.3.1 Middle East & Africa Human Recombinant SCF Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Human Recombinant SCF Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Human Recombinant SCF Market Drivers
  • 12.2 Human Recombinant SCF Market Restraints
  • 12.3 Human Recombinant SCF Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Human Recombinant SCF and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Human Recombinant SCF
  • 13.3 Human Recombinant SCF Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Human Recombinant SCF Typical Distributors
  • 14.3 Human Recombinant SCF Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Human Recombinant SCF. Industry analysis & Market Report on Human Recombinant SCF is a syndicated market report, published as Global Human Recombinant SCF Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Human Recombinant SCF market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo